Data, Drugs & Devices: Decoding Digital Health

Digital Health is now a major focus not only for the life sciences and healthcare industry, but also for technology, telecoms, and retail companies, who are expanding their services and products into this space. From medical apps, digital therapeutics and AI diagnostic tools to blood glucose monitors, medical software and electronic personal health records, digital technologies play an integral role in how we prevent, treat, and manage health conditions.

Join us for our Digital Health event on Thursday 20th October in Brussels, where our international Life Sciences and Tech experts will come together and discuss some of the key legal issues and trends surrounding this dynamic topic, including data, regulation, privacy, tech contracting, financing and intellectual property.

We will also be joined by our consultancy arm OXYGY and special guest speakers from Amazon, IQVIA, Takeda, Novo Nordisk, Chiesi, BioLizard and Philippe De Backer, former MEP and Minister in the Belgian Federal Government, who will give their industry perspectives on how digital technologies are transforming the life sciences and healthcare world.

The event will be a full-day interactive mix of plenary, panel and break-out sessions, finishing off with networking drinks and canapes.

We look forward to welcoming you in Brussels!

09:00 - 09:30

Breakfast and Registration

09:30 - 10:00

Keynote Presentation:

Speaker: Dennis Lauth, Business Development Leader Life Sciences/Healthcare, Amazon Web Services

How digitalisation is impacting the Life Sciences & Healthcare industry

  • Key areas of business which are susceptible to digitalisation (e.g., patient interaction, patient monitoring, back office, supply chain and logistics etc.)
  • Creation of new key areas of business (e.g., direct patient interaction for life sciences companies)
  • New emerging technologies that will enable or drive these changes. The roles of blockchain, tokens, AI, data, and digital IDs
  • Focus on move towards data centricity: What does this look like for LSH organisations, what are the general / organisation-level challenges, what are the issues being faced by legal teams in enabling this?
10:00 - 11:00

Panel Discussion


  • Massimo Mura, Site IT Lead, Takeda
  • Sam De Decker, Business Development Manager, BioLizard
  • Philippe de Backer, Newton Biocapital and ex-Minister of State

Moderator: Sally Shorthose, Bird & Bird

Followed by Q&A with audience

11:00 - 11:30


11:30 - 12:30 

Breakout session one: Getting a digital healthcare product to market

  • Thought process / decision tree of getting a digital healthcare product to market
  • Regulatory hurdles
  • Deciphering which products or services fall into specific regulatory regimes
  • Handling and contracting for the relevant technologies / key tech related issues and challenges:
    • Key supplier / customer relationships and tech-driven legal issues to consider when designed contracting frameworks
    • Ts & Cs that are both legally compliant but also achieve efficient commercial outcomes

Gianluigi Pertusi, Business Unit Consumer Care Director, Chiesi

Christian Lindenthal, Bird & Bird

Vera Pellegrin, Oxygy

Günter Kloucek, Oxygy

Breakout session two: Enabling data driven innovation

  • Protection, innovation and collaboration as part of data stewardship and the role of lawyers in developing a data innovation strategy
  • Anonymisation as the boundary between personal and non-personal data
  • Protection of non-personal data
  • Trends in data regulation (data localisation and the draft EU Data Act)
  • Managing data in collaborations and data sharing frameworks
  • Developing an open data strategy

Bird & Bird: Toby Bond & Emma Drake

12:30 - 13:30


13:30 - 14:00

Fireside Chat with IQVIA –how is de-identification facilitating innovative uses of data?

  • Chris Johnson, Director, Business Development, IQVIA
  • Ruth Boardman, Partner, Data Protection, Bird & Bird
14:00 - 14:45

Panel: Digital Collaborations: Tech meets Healthcare

The cultural differences when contracting in healthcare and tech.

  • How to achieve successful collaborations between healthcare providers/life sciences companies and technology companies
  • Exploring the cultural differences when contracting in healthcare and tech, e.g., to issues such as liability and IP
  • Which regulatory issues can apply to collaborations and which partner is responsible for ensuring compliance?


  • Christian Degnboel Østergaard, Corporate Counsel Digital Health, Novo Nordisk
  • Dennis Lauth, Business Development Leader Life Sciences/Healthcare, Amazon Web Services
  • Hugues Botman, Vice President People Experience, Regional Lead, Pfizer
  • Günter Kloucek, Director, Life Sciences & Healthcare, Oxygy

Moderator: Miriam Ballhausen, Bird & Bird

Followed by Q&A with audience

14:45 - 15:15  


15:15 - 16:00

Breakout session three: Protecting and scaling digital healthcare products

  • IP protection strategies for digital healthcare.
  • Scale up challenges (financing and investment, cross border expansion etc).

Bird & Bird: Tjibbe Douma & Hester Borgers

Breakout session four: Planning for success in digitalisation projects

  • What to think about at the outset of a project
  • Key tech contracting issues in the lifecycle of a project (including how to successfully deal with implementation and exit)
  • The differences with contracting for AI vs traditional technologies
  • Lessons learned

Bird & Bird: Richard McMorris & Ben Woodfield

16:00 onwards

Conclusion followed by networking drinks


The Hotel
Boulevard de Waterloo 38, 1000

Upcoming events

More Events